US Pharma MarketingLG AI Research, D&D Pharmatech sign agreement for oral peptide drugs
LG AI Research and D&D Pharmatech have entered into an agreement to collaborate on the development of next-generation oral peptide drugs, the companies announced following a signing ceremony held at the LG Twin Towers in Yeouido, Seoul. The companies aim to create a tablet-form treatment to improve the safety and absorption rates of peptide drugs. The project focuses on the joint discovery and development of oral peptide therapeutics. Credit: Gorodenkoff / Shutterstock.com. LG AI Research and D&D Pharmatech have entered an agreement to collaborate on the development of next-generation oral peptide drugs, the companies announced following a signing ceremony held…
LG AI Research and D&D Pharmatech have entered into an agreement to collaborate on the development of next-generation oral peptide drugs, the companies announced following a signing ceremony held at the LG Twin Towers in Yeouido, Seoul.
Source: Pharmaceutical Technology